|
Volumn 290, Issue 5498, 2000, Pages 1959-1962
|
Glucose-dependent insulin release from genetically engineered K cells
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GASTRIC INHIBITORY POLYPEPTIDE;
GLUCOSE;
INSULIN;
POLYPEPTIDE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
DIABETES CONTROL;
DIABETES MELLITUS;
ENDOCRINE CELL;
GENE EXPRESSION;
GENE THERAPY;
GENETIC ENGINEERING;
HUMAN;
INSULIN RELEASE;
MOUSE;
NONHUMAN;
PANCREAS CELL;
PRIORITY JOURNAL;
TISSUE DISTRIBUTION;
TRANSGENE;
ANIMALS;
BLOOD GLUCOSE;
CELL LINE;
CLONING, MOLECULAR;
DIABETES MELLITUS, EXPERIMENTAL;
ENTEROENDOCRINE CELLS;
GASTRIC INHIBITORY POLYPEPTIDE;
GENE EXPRESSION;
GENE THERAPY;
GENETIC ENGINEERING;
GLUCOSE;
GLUCOSE TOLERANCE TEST;
HUMANS;
INSULIN;
MICE;
MICE, TRANSGENIC;
PROINSULIN;
PROMOTER REGIONS (GENETICS);
PROTEIN PRECURSORS;
STEM CELLS;
STREPTOZOCIN;
TRANSFECTION;
TRANSGENES;
TUMOR CELLS, CULTURED;
ANIMALIA;
|
EID: 0034623757
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.290.5498.1959 Document Type: Article |
Times cited : (263)
|
References (34)
|